# A Study of Dexlansoprazole Modified Release (MR) in Gastroesophageal Reflux Disease (GERD) Participants in the Russian Federation

> **NCT04311541** · — · WITHDRAWN · sponsor: **Takeda**

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04311541
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-03-15
- **Primary completion:** 2021-06-15
- **Final completion:** 2022-01-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Business Decision; No Safety Or Efficacy Concerns
- **Last updated:** 2020-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04311541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04311541, "A Study of Dexlansoprazole Modified Release (MR) in Gastroesophageal Reflux Disease (GERD) Participants in the Russian Federation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04311541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*